Abstract
Objective
To study the various comorbidities and their impact on outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected children.
Methodology
Review of medical records of 120 children (58.4% males), aged 1 month to 18 years, admitted between 1 March and 31 December, 2020 with at least one positive RT-PCR test for SARS-CoV-2. Clinical and demographic variables were compared between children with and without co-morbidities.
Results
62 (51.7%) children had comorbidities. The most common comorbidity was tuberculosis (32.3%) followed by other infections (27.4%) and hematological (19.4%) conditions. Fever (89.2%) was the most common clinical feature followed by respiratory (52.5%) and gastrointestinal (32.5%) manifestations. There was no significant difference in the severity of COVID illness, length of hospital stay and adverse outcomes (ventilation and mortality) among children with and without comorbidities.
Conclusion
The presence of a comorbid illness in pediatric inpatients with COVID-19 did not impact the illness severity, length of hospitalization, ventilation requirement and mortality.
Keywords: Mortality, Outcome, Tuberculosis, Ventilation
Footnotes
Ethical clearance
Institutional Ethical Committee, LH Medical College; No. LHMC/IEC/2020/97, dated November 6, 2020.
Contributors
DK: collected data and wrote the initial manuscript; VK, PK: critically analyzed the manuscript; PS: helped in data collection and revision of manuscript. All the authors read and approved the final manuscript.
Funding
None
Competing interests
None stated
References
- 1.Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. European Respiratory J. 2020; 55 [DOI] [PMC free article] [PubMed]
- 2.Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in-patients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020;395:1054–62. doi: 10.1016/S0140-6736(20)30566-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 Infection and pediatric comorbidities: A systematic review and meta-analysis. Intern J Infect Dis. 2021;103:246–56. doi: 10.1016/j.ijid.2020.11.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Valdres J M, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357–63. doi: 10.1370/afm.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Clinical management of severe acute respiratory infection when COVID-19 is suspected. Accessed October 31, 2020. Available at: https://www.who.int/publications-detail/clinical-management-of-severe-acuterespiratory-infection-when-novel-coronavirus-(ncov)-infection-issuspected
- 6.Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; e20200702.
- 7.Meena J, Yadav J, Saini L, et al. Clinical features and outcome of SARS-CoV-2 infection in children: A systematic review and meta-analysis. Indian Pediatr. 2020;57:820–26. doi: 10.1007/s13312-020-1961-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shrinivasan R, Rane S, Pai M. India’s syndemic of Tuberculosis and COVID-19. BMJ Global Health. 2020;5:e003979. doi: 10.1136/bmjgh-2020-003979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Girmenia C, Gentile G, Micozzi A, et al. COVID-19 in patients with hematologic disorders undergoing therapy: Perspective of a large referral hematology center in Rome. Acta Haematol. 2020;143:574–82. doi: 10.1159/000510769. [DOI] [PubMed] [Google Scholar]
- 10.Adeiza SS, Shuaibu AB, Shuaibu GM. Random effects meta-analysis of COVID-19/S. Aureus partnership in co-infection GMS. Hygiene and Infection Control. 2020;15:2196–5226. doi: 10.3205/dgkh000364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Saddique A, Rana MS, Alam MM, et al. Emergence of co-infection of COVID-19 and dengue: A serious public health threat. J Infect. 2020;81:16–18. doi: 10.1016/j.jinf.2020.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Collange O, Tacquard C, Delabranche X, et al. Coronavirus disease 2019: associated multiple organ damage. Open Forum Infect Dis. 2020;7:249. doi: 10.1093/ofid/ofaa249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rao S, Gavali V, Prabhu S, et al. Outcome of children admitted with SARS-CoV-2 infection: Experiences from a pediatric public hospital. Indian Pediatr. 2021;58:358–62. doi: 10.1007/s13312-021-2196-4. [DOI] [PMC free article] [PubMed] [Google Scholar]